雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Pharmacokinetics and usage of drug for treatment of osteoporosis. Pharmacokinetics of bisphosphonate. Nakamura Midori 1 , Koide Masanori 2 , Udagawa Nobuyuki 3 1Department of Biochemistry, Institute for Oral Science, Matsumoto Dental University, Japan. 2Institute for Oral Science, Matsumoto Dental University, Japan. 3Department of Biochemistry, Institute for Oral Science, Matsumoto Dental University, Japan. pp.1561-1570
Published Date 2016/10/28
DOI https://doi.org/10.20837/4201611041
  • Abstract
  • Look Inside
  • Reference
  • Cited by

 The objective of treating osteoporosis is to prevent fractures. Bisphosphonates inhibit bone resorption and increase bone density, thereby suppressing the occurrence of fractures. Bisphosphonates have a high affinity for hydroxyapatite. About 20-80%of bisphosphonates absorbed in vivo is adsorbed onto the bone surface. However, the absorption rates of orally ingested bisphosphonates are less than 1%. Bisphosphonates adhered to the bone surface are specifically incorporated into cells upon bone resorption by osteoclasts. Thus, the cytoskeleton of osteoclasts is destroyed, and apoptosis is induced to suppress bone resorption. This article overviews the mechanisms of action and pharmacokinetics of bisphosphonates.



基本情報

電子版ISSN 印刷版ISSN 0917-5857 医薬ジャーナル社

関連文献

もっと見る

文献を共有